psychedelics
Nova Mentis looks at potential psilocybin treatment for obesity and diabetes
People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.
Awakn Life Sciences starts study on ketamine treatment for gambling addiction
Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.
Vancouver’s Havn Life announces first psilocybin mushroom harvest in Jamaica
Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.
Psychedelics researcher explains why a bad trip is a good one after all
Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.
Psychedelics linked to better mental health amid COVID-19 pandemic
A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.
Braxia Health opens new ketamine clinic in Montreal for mental health disorders
The new Braxia Health clinic represents the company’s fourth ketamine facility in Canada.
Mescaline study shows high potential for mental health, low chance of addiction
Researchers from The Netherlands, U.S. and U.K. conducted a study with 452 respondents who have used mescaline.
BetterLife Pharma invents implant to control release of psychedelic drugs
The Vancouver-based BetterLife Pharma Inc. develops psychedelic products and delivery systems.
Ayahuasca brings cheer without side effects of pharmaceutical antidepressants
A new study shows that ayahuasca offers an option in dealing with depression